EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Arg177 and Asp159 from dog prion protein slow liquid–liquid phase separation and inhibit amyloid formation of human prion protein

Xiang-Ning Li, Yuan Gao, Yang Li, Jin-Xu Yin, Chuan-Wei Yi, Han-Ye Yuan, Jun-Jie Huang, Li-Qiang Wang, Jie Chen, Yi Liang

Journal of Biological Chemistry · 2023

DOI: 10.1016/j.jbc.2023.105329 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Biological Chemistry, 2023. Verfasst von Xiang-Ning Li und 9 weiteren Autor:innen. Beteiligte Einrichtung: Hubei Key Laboratory of Cell Homeostasis, College of Life Sciences, TaiKang Center for Life and Medical Sciences, Wuhan University, Wuhan, China. Hauptthemen laut MEDLINE: Prions, Prion Diseases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Shenzhen Science and Technology Innovation Committee, Fundamental Research Funds for the Central Universities, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Prion diseases are a group of transmissible neurodegenerative diseases primarily caused by the conformational conversion of prion protein (PrP) from α-helix-dominant cellular prion protein (PrPC) to β-sheet-rich pathological aggregated form of PrPSc in many mammalian species. Dogs exhibit resistance to prion diseases, but the mechanism behind the phenomenon remains poorly understood. Compared with human PrP and mouse PrP, dog PrP has two unique amino acid residues, Arg177 and Asp159. Because PrPC contains a low-complexity and intrinsically disordered region in its N-terminal domain, it undergoes liquid-liquid phase separation (LLPS) in vitro and forms protein condensates. However, little is known about whether these two unique residues modulate the formation of PrPC condensates. Here, using confocal microscopy, fluorescence recovery after photobleaching assays, thioflavin T binding assays, and transmission electron microscopy, we report that Arg177 and Asp159 from the dog PrP slow the LLPS of full-length human PrPC, shifting the equilibrium phase boundary to higher protein concentrations and inhibit amyloid formation of the human protein. In sharp contrast, His177 and Asn159 from the human PrP enhance the LLPS of full-length dog PrPC, shifting the equilibrium phase boundary to lower protein concentrations, and promote fibril formation of the canid protein. Collectively, these results demonstrate how LLPS and amyloid formation of PrP are inhibited by a single residue Arg177 or Asp159 associated with prion disease resistance, and how LLPS and fibril formation of PrP are promoted by a single residue His177 or Asn159. Therefore, Arg177/His177 and Asp159/Asn159 are key residues in modulating PrPC liquid-phase condensation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PrionsPrion DiseasesMiceDogsHumansAnimalsPrion ProteinsAmyloidAmyloidogenic ProteinsMammals

Stichwörter der Autor:innen

dog prion proteinprion disease resistanceprion diseasesprion proteinprotein aggregationprotein liquid–liquid phase separation

Substanzen

Prion ProteinsPrionsAmyloidAmyloidogenic Proteins

Autor:innen und Institutionen

  • Hubei Key Laboratory of Cell Homeostasis, College of Life Sciences, TaiKang Center for Life and Medical Sciences, Wuhan University, Wuhan, China.
  • Hubei Key Laboratory of Cell Homeostasis, College of Life Sciences, TaiKang Center for Life and Medical Sciences, Wuhan University, Wuhan, China; Wuhan University Shenzhen Research Institute, Shenzhen, China.
  • Hubei Key Laboratory of Cell Homeostasis, College of Life Sciences, TaiKang Center for Life and Medical Sciences, Wuhan University, Wuhan, China; Wuhan University Shenzhen Research Institute, Shenzhen, China. Electronic…

Förderung

  • Shenzhen Science and Technology Innovation Committee
  • Fundamental Research Funds for the Central Universities
  • National Natural Science Foundation of China
  • Chinese Academy of Sciences
  • Wuhan University Zhongnan Hospital
  • China Postdoctoral Science Foundation
  • Universität Zürich

Zitieren

APA

Li, X. N., Gao, Y., Li, Y., Yin, J. X., Yi, C. W., Yuan, H. Y., Huang, J. J., Wang, L. Q., Chen, J., & Liang, Y. (2023). Arg177 and Asp159 from dog prion protein slow liquid–liquid phase separation and inhibit amyloid formation of human prion protein. Journal of Biological Chemistry. https://doi.org/10.1016/j.jbc.2023.105329

Vancouver

Li XN, Gao Y, Li Y, Yin JX, Yi CW, Yuan HY, et al. Arg177 and Asp159 from dog prion protein slow liquid–liquid phase separation and inhibit amyloid formation of human prion protein. Journal of Biological Chemistry. 2023. doi:10.1016/j.jbc.2023.105329

BibTeX
@article{Li2023,
  author = {Li, Xiang-Ning and Gao, Yuan and Li, Yang and Yin, Jin-Xu and Yi, Chuan-Wei and Yuan, Han-Ye and Huang, Jun-Jie and Wang, Li-Qiang and Chen, Jie and Liang, Yi},
  title = {Arg177 and Asp159 from dog prion protein slow liquid–liquid phase separation and inhibit amyloid formation of human prion protein},
  journal = {Journal of Biological Chemistry},
  year = {2023},
  doi = {10.1016/j.jbc.2023.105329}
}
Kostenlos starten →